Connect with us


Series 3 of BBC Documentary ‘Hospital’ to be filmed in Nottingham



The third series of the BBC2 documentary that has been commended across the NHS – ‘Hospital’ – will be filmed at Nottingham University Hospitals NHS Trust (NUH).

Work has already started on the third series of ‘Hospital,’ which is coming to Nottingham after two series of the acclaimed documentary at Imperial College Healthcare NHS Trust in London.

The Nottingham trust has recently been in the news for their ‘innovative’ #EndPJparalysis and #EDFit2Sit campaigns.

The six-part series will go behind the scenes at Queen’s Medical Centre and Nottingham City Hospital to show how staff are managing and responding to the competing pressures and demands on a daily basis to ensure patients get the best possible care. It also aims to show how staff are working with partners across the health and social care system to respond to changing needs, against the backdrop of the NHS’s toughest ever financial challenge.

Laura Skaife-Knight, NUH’s Director of Communications and External Relations, said: “Taking part in ‘Hospital’ was a carefully considered decision, but in the end an easy one to make. NUH has an ambition to be the NHS leader in openness and transparency and giving access to the cameras to follow the stories of our patients and staff is one of the ways we will achieve this.

“What is unique about ‘Hospital’ is that it goes beyond the headlines and gets under the skin of the challenges our staff experience every day and very often the difficult decisions they face in their efforts to do what is right for patients, their loved ones and carers.

“People working across the NHS can relate to these stories, many of which are replicated in many hospitals and healthcare settings up and down the country. We have incredibly dedicated staff working across our hospitals, many leading the way in their fields nationally; in some cases internationally – and yet too often their jobs are made all the more difficult because of the imperfect systems in which they are operating at both Trust and system level.”

Series 3 will be filmed at NUH in January and February 2018 and is expected to be broadcast in Spring 2018.

Lorraine Charker-Phillips, Head of Programmes for Label 1, said: “When we first met the team at NUH we were really impressed by their pride, passion and enthusiasm for the work that they do. We very much look forward to making the third series of ‘Hospital’with them.”

You can watch the previous serious of ‘Hospital’ on BBC iPlayer.

Continue Reading
Join the discussion...

Leave a Reply

Your email address will not be published. Required fields are marked *


Royal College of Midwives to end campaign to promote ‘normal births’




The Royal College of Midwives ends their campaign for “normal births” to avoid making mothers who opt for medical interventions feel like failures.

The Royal College of Midwives (RCM) has been running a continuous campaign since 2005 to encourage expectant mothers to give birth without medical interventions such as; epidurals, inductions and caesareans.

Currently, around 40% of mothers give birth without medical interventions. 20% less than 30 years ago. But experts say a significant number of these are due to the increase in more risky pregnancies.

Prof Cathy Warwick, the Chief Executive of the RCM, said;

“There was a danger that if you just talk about normal births – and particularly if you call it a campaign – it kind of sounds as if you’re only interested in women who have a vaginal birth without intervention”.

“What we don’t want to do is in any way contribute to any sense that a woman has failed because she hasn’t had a normal birth. Unfortunately, that seems to be how some women feel.”

“What we don’t want to do is in any way contribute to any sense that a woman has failed because she hasn’t had a normal birth. Unfortunately that seems to be how some women feel.”

Midwives, will instead, start to use the term “physiological births” to describe those without interventions.

Continue Reading


Pancreatic cancer patients to have routine access to life extending drug after new deal



NICE has recommended nab-paclitaxel for routine NHS use after the company agreed a confidential price discount and provided more evidence on its effectiveness.

Nab-paclitaxel, also known as Abraxane, made by Celgene will be routinely available as an option for patients with pancreatic cancer that has progressed.

When Abraxane is added to a standard chemotherapy, called gemcibatine the evidence has found it extends life by an average of 2.4 months.

If other combination chemotherapy treatments are unsuitable for a patient, NICE recommends offering Abraxane instead of this standard chemotherapy on its own.

It works by blocking the action of the proteins within cancer cells that cause them to grow and divide.

NICE has reviewed its guidance from 2015 which did not recommend Abraxane for routine NHS use for not being cost-effective.

Professor Carole Longson, director of the centre for health technology evaluation at NICE, said: The life expectancy of pancreatic cancer is poor, with patients usually living for only up to 6 months. It’s incredibly important that patients and families affected by this disease are able to have routine access to this life extending treatment.”

There are almost 10,000 new cases of pancreatic cancer each year in the UK, and less than 1% survive for 10 or more years.

This is a final appraisal determination for Abraxane. The company, healthcare professionals and patient/carer organisations now have until Friday 1 September to appeal the decision.

Continue Reading